Iron Deficiency Linked to Poor Outcomes in Kidney Transplant Recipients
HCPLive
MARCH 19, 2024
Iron deficiency, independent of anemia, may be a potentially modifiable target to improve patient-reported outcomes after kidney transplantation.
Combined Tacrolimus, Belatacept Regimen Improves Post-Kidney Transplant Outcomes
HCPLive
JANUARY 30, 2025
Findings suggest the benefits of combined belatacept and tacrolimus immunosuppression after kidney transplantation for patient and all-cause graft survival.
Transplant 
113
113 
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
Journal of Clinical Investigation - Cardiology
MARCH 1, 2024
Long-term organ transplant survival remains suboptimal, and life-long immunosuppression predisposes transplant recipients to an increased risk of infection, malignancy, and kidney toxicity. Promoting the regulatory arm of the immune system by expanding Tregs may allow immunosuppression minimization and improve long-term graft outcomes.
Transplant 133
133 
Revolutionary Genomic Study Sheds Light on Immune Microenvironment in Transplanted Pediatric Hearts
DAIC
FEBRUARY 13, 2024
THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. This helps us gain a comprehensive understanding of the immune response dynamics within transplanted hearts."
Transplant 111
111 
Prolonged Perfusion Preserves Donor Livers, Allows Flexible Transplantation Timeline
HCPLive
JANUARY 12, 2024
Liver transplantation after prolonged preservation with dual hypothermic oxygenated machine perfusion yielded similar outcomes to standard perfusion, showing no compromised donor liver quality and equal safety for recipients.
Transplant 99
99 
Machine Perfusion Could Help Address Transplant Crisis for Pediatric Liver Diseases
HCPLive
NOVEMBER 9, 2024
New data from the UNOS database presented at NASPGHAN 2024 details characteristics and outcomes of pediatric liver transplant patients receiving machine perfused organs.
Transplant 92
92 
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
DAIC
MAY 31, 2024
By the end of the study cardiologists performed 10% fewer biopsies in the first year post-transplant and 40% fewer in the second year post-transplant despite an increase in follow-up biopsy rates for dual positives. Hanna , CareDx President and CEO.
Heart Transplant 105
105 
PSC Linked to Worse Transplant, Mortality Outcomes Than PBC, Autoimmune Hepatitis
HCPLive
DECEMBER 23, 2024
Patients with PSC had worse death, transplant, liver-related mortality, and liver-related decompensation outcomes than PBC and autoimmune hepatitis.
Transplant 64
64 
HCV+ Organs Offer Better Waitlist, Survival Outcomes for Transplantation
HCPLive
NOVEMBER 5, 2024
Direct-acting antiviral agents have enabled more availability for organ transplant.
Transplant 59
59 
Immunosuppressant adherence after heart transplantation: a review on detection, prevention, and intervention strategies in a multidisciplinary
Frontiers in Cardiovascular Medicine
MARCH 9, 2025
Heart transplantation is an effective treatment for end-stage heart disease, and postoperative patients' medication adherence is crucial for transplantation outcomes and long-term survival.
Minjee Kim, MD: Understanding Sleep’s Impact on Post-Liver Transplant Outcomes
HCPLive
NOVEMBER 17, 2024
Kim explains how poor sleep is linked to negative impacts on mental health, physical health, and frailty after liver transplantation.
Transplant 59
59 
The impact of pre-transplant ventricular assist device support in pediatric patients with end-stage heart failure on the outcomes of heart transplantation—“a single center experience”
Frontiers in Cardiovascular Medicine
JANUARY 22, 2025
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heart failure. Patients were divided into two groups: with pre transplant ventricular assist device (VAD) support and without VAD support.
Genomic study sheds light on immune microenvironment in transplanted pediatric hearts
Medical Xpress - Cardiology
FEBRUARY 12, 2024
Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.
Transplant 70
70 
Current Kidney Transplant Policies Disadvantage Certain Adolescents, Young Adults
HCPLive
JANUARY 28, 2025
Patients who started dialysis as children but were not waitlisted until young adulthood faced worse outcomes than those who were listed before turning 18.
Transplant 96
96 
Using stem cell-derived heart muscle cells to advance heart regenerative therapy
Science Daily - Heart Disease
APRIL 26, 2024
Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. The highly positive outcomes observed in primate models highlight the potential of this strategy. However, the risk of arrhythmias following this procedure is reportedly high.
Transplant 127
127 
Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
Cardiovascular Diabetology
FEBRUARY 20, 2025
Cardiovascular disease is a leading cause of post-transplant mortality in kidney transplant recipients (KTRs), especially those with diabetes. Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) hav.
Transplant 52
52 
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study
DAIC
JANUARY 11, 2024
In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ. utilizing the Paragonix SherpaPak CTS (p=0.022).
Transplant 111
111 
The impact of bleeding on outcomes following lung transplantation: a retrospective analysis using the universal definition of perioperative bleeding
Journal of Cardiothoracic Surgery
JULY 24, 2024
Lung transplantation (LT) represents a high-risk procedure for end-stage lung diseases. This study describes the outcomes of patients undergoing LT that require massive transfusions as defined by the universal.
Transplant 52
52 
Qazi Corner, Edition 7: ERCP Timing, GLP-1 RA Considerations, Seronegative Villous Atrophy
HCPLive
AUGUST 23, 2024
The third quarterly issue of 2024 reviews early versus late ERCP outcomes post-transplant, the impact of GLP-1RA use on endoscopic management, and the differential diagnosis of seronegative villous atrophy.
Transplant 105
105 
Standardized risk-stratified cardiac assessment and early posttransplant cardiovascular complications in kidney transplant recipients
Frontiers in Cardiovascular Medicine
JANUARY 23, 2024
Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in kidney transplant recipient (KTR). There is a dearth of standardized guidelines on optimal cardiovascular evaluation of transplant candidates. Posttransplant MACE has a negative effect on grafts and patient outcomes.
Transplant 64
64 
Outcome of Cardiac Implantable Electronic Devices in Pediatric Heart Transplant Recipients
HeartRhythm
AUGUST 21, 2024
Among pediatric patients undergoing orthotopic heart transplantation (OHT), 1-12% are reported to need a permanent pacemaker (PPM).1 1 There are limited studies on the outcomes of PPM placement, and the role of implantable cardioverter-defibrillator (ICD) in pediatric OHT remains unclear.
Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium
Journal of Cardiothoracic Surgery
SEPTEMBER 22, 2024
The outcome of heart transplantation is significantly affected by perioperative infections. Individualised immunosuppression strategies are essential to reduce the risk of such infections.
Hematopoietic Stem Cell Transplantation Improves Pediatric SCD Outcomes
HCPLive
APRIL 9, 2024
A systematic review and meta-analysis of HSCT in children with sickle cell disease demonstrated pooled survival rates exceeding 90%.
Determinants of survival following heart transplantation in adults with congenital heart disease
Journal of Cardiothoracic Surgery
FEBRUARY 9, 2024
We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur. Adult patients surviving with congenital heart disease (ACHD) is growing.
Right Ventricular Function on Cardiovascular Magnetic Resonance Imaging and Long-Term Outcomes in Stable Heart Transplant Recipients
Circulation: Cardiovascular Imaging
APRIL 2, 2024
BACKGROUND:In heart transplant recipients, right ventricular (RV) dysfunction may occur for a variety of reasons. Whether RV dysfunction in the stable phase after heart transplantation is associated with long-term adverse outcomes is unknown. years after heart transplantation were included. Over a median follow-up of 4.4
Heart transplantation for pediatric patients with malignant arrhythmias: Indications and Outcomes
HeartRhythm
OCTOBER 7, 2024
When intractable, heart transplant (HTX) can become the only viable treatment. Arrhythmias can lead to cardiac arrest (CA) and heart failure. This rare, high-risk cohort has not been reported as a distinct group.
What happens to patients awaiting urgent transplantation for refractory electrical storm when they are not transplanted?
HeartRhythm
SEPTEMBER 17, 2024
Urgent heart transplantation (HTx) may be considered when all previous strategies fail (1), albeit with substantial post-operative mortality (1). Although HTx is considered as a bail-out strategy, no data exist regarding outcomes of refractory ES patients listed for urgent HTx but ultimately not transplanted during the acute phase.
Transplant 40
40 
Early Heart Transplant Experience With Normothermic Regional Perfusion
American College of Cardiology
DECEMBER 4, 2024
For heart transplantation following donation after circulatory death (DCD HT), what are the short-term outcomes associated with organ procurement using a normothermic regional perfusion (NRP) strategy compared to a direct procurement and perfusion (DPP) strategy?
An explainable machine learning approach using contemporary UNOS data to identify patients who fail to bridge to heart transplantation
Frontiers in Cardiovascular Medicine
MAY 19, 2024
BackgroundThe use of Intra-aortic Balloon Pump (IABP) and Impella devices as a bridge to heart transplantation (HTx) has increased significantly in recent times. Out of them, 12% had primary outcomes indicating Status 2 failure. Our ML models were based on 19 variables from the UNOS data.
Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care
DAIC
FEBRUARY 21, 2024
As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.
Pediatrics 105
105 
RELIEVE-HF: Interatrial shunt in patients with heart failure
Cardiology Update
APRIL 25, 2024
The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Among patients with HFpEF, those who received the shunt experienced poor outcomes than those who did not.
The comparative impact of central vs. peripheral VA-ECMO cannulation on postoperative graft dysfunction in lung transplantation: a retrospective analysis
Frontiers in Cardiovascular Medicine
FEBRUARY 24, 2025
BackgroundLung transplantation (LTx) is the definitive treatment for end-stage pulmonary diseases, with venoarterial extracorporeal membrane oxygenation (VA-ECMO) used as a common perioperative support. Data included recipient/donor demographics, preoperative status, and follow-up outcomes.
Transplant 40
40 
Organ Donation After Euthanasia Can Safely Expand Kidney Donor Pool, Study Finds
HCPLive
SEPTEMBER 25, 2024
Leveraging deceased donor kidney transplantation data, study results suggest DCD-V kidney transplantation has similar short- and long-term outcomes versus DCD-III and DBD.
Transplant 64
64 
Abstract 26: First-in-human Phase 1/2a Study of Intracerebral Transplantation using Embryonic-derived Neural Stem Cells (NR1) for Chronic Ischemic Stroke (NCT04631406): 12 Months Outcomes
Stroke Journal
JANUARY 30, 2025
The safety&efficacy of NR1 intracerebral transplantation in chronic stroke patients was assessed over 12 months.Methods:Inclusion Criteria: 18-75 yo; 6-60 mos post-ischemic subcortical MCA stroke; mRS 3-4. Subjects were transplanted with 2.5M, 5M, 10M or 20M. UE FMMS improvement surpassed vagal nerve stimulation outcomes.
Transplant 40
40 
Smidt Heart Institute Experts Selected to Join JACC Editorial Team
DAIC
JUNE 24, 2024
Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. She has been a section editor for Circulation: Cardiovascular Outcomes and Research, authored book chapters, and in 2022 was a finalist for the Samuel A.
Heart Failure 100
100 
Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited.
Heart Failure 124
124 
Abstract 4146828: Downregulation of ADAR1 Attenuates Hypothermic Cardioprotection in Aged Donor Hearts During Transplantation
Circulation
NOVEMBER 11, 2024
Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need. Aged donor hearts, despite their availability, exhibit increased primary graft dysfunction and decreased survival rates post-transplantation.
Transplant 40
40 RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type
DAIC
APRIL 6, 2024
Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. Researchers tracked outcomes in each participant for at least one year and up to two years.
Abstract WP381: Spatiotemporal imaging and molecular signatures of stem cell transplant-driven recovery in stroke-injured brains
Stroke Journal
JANUARY 30, 2025
Introduction:Intraparenchymal transplantation (tx) of human neural stem cells is in clinical trial for chronic ischemic stroke, but the mechanisms of action are unknown. Most NR1-treated rats (94%) exhibited a new cortical T2-FLAIR signal, associated with positive outcomes, compared to 33% in the vehicle group.
Transplant 40
40 
Heart Failure Treatment Outcomes and Contraindications
HCPLive
MAY 21, 2024
Ashley Malliett, DMSc, MPAS, PA-C, discusses the importance of timely diagnosis and initiated care, as well as contraindications for transplants and LVAD.
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association
Circulation
MARCH 11, 2024
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking.
Transplant 45
45 
Using Stem Cell-derived Heart Muscle Cells to Advance Heart Regenerative Therapy
DAIC
APRIL 30, 2024
Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. The highly positive outcomes observed in primate models highlight the potential of this strategy.
Transplant 105
105 
Resynchronization-defibrillation for heart failure shows long-term benefits
Cardiology Update
JANUARY 22, 2024
Long-term outcomes were assessed at the eight highest-enrolling sites. The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. Secondary outcomes were experienced by 77.7% to 0.92; P=0.002).
Heart Failure 115
115 
Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy
Circulation
JANUARY 9, 2025
BACKGROUND:The United Network of Organ Sharing made changes to the priority for allocation of hearts for transplantation (HT) in 2016 for pediatric patients and 2018 for adult patients. Children with cardiomyopathy and adults with CHD did not experience the mortality benefits experienced by adults with cardiomyopathy and children with CHD.
Let's personalize your content